Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HP INCHPQ · Entity 642 | Director · Interim CEO | February 03, 2026 | February 05, 2026 |
| KEYCORP /NEW/KEY · Entity 3220 | Director | July 01, 2021 | July 06, 2021 |
| MARSH & MCLENNAN COMPANIES, INC.MRSH · Entity 1501 | Director | August 15, 2026 | August 18, 2026 |
| TAKEDA PHARMACEUTICAL CO LTDTAK · Entity 2662 | Director | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HP INC
Report date February 03, 2026 · Filed February 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 344,149 |
Reported balance
After 2026-02-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-03 · Grant · Acquired 344,149 · Balance 344,149 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2: On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.
F2: On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock.
KEYCORP /NEW/
Report date July 01, 2021 · Filed July 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 19,587 |
Reported balance
After 2021-07-01 transaction · row 1
1 source rowRow 1 · 2021-07-01 · Exercise / conversion · Acquired 6,781 · Balance 19,587 F1: Each Deferred Share is the economic equivalent of one Common Share. |
| Deferred SharesSEC Table II · derivative / convertible security · Expires 2021-07-01 | Direct | 27,263 |
Reported balance
After 2021-07-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-07-01 · Exercise / conversion · Disposed 6,781 · Balance 27,263 F1: Each Deferred Share is the economic equivalent of one Common Share. F3: Includes approximately 288 dividend-equivalent deferred shares accrued under the Deferred Share Plan in June 2021. |
| Common SharesSEC Table I · non-derivative | IndirectBy Trust | 11,778 |
Reported balance
Holding disclosure · report date 2021-07-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 11,778 F2: These shares are held in a living trust. The reporting person is trustee of the trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Share is the economic equivalent of one Common Share.
F2: These shares are held in a living trust. The reporting person is trustee of the trust.
F3: Includes approximately 288 dividend-equivalent deferred shares accrued under the Deferred Share Plan in June 2021.
MARSH & MCLENNAN COMPANIES, INC.
Report date August 15, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,617 |
Reported balance
After 2026-08-15 transaction · row 1
1 source rowRow 1 · 2026-08-15 · Grant · Acquired 192 · Balance 1,617 F1: Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan.
TAKEDA PHARMACEUTICAL CO LTD
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 4,595 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 3,800 · Balance 4,595 F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. |
| Tax Obligation AwardSEC Table II · derivative / convertible security · Expires 2029-06-01 | Direct | 1,319 |
Reported balance
After 2026-07-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-01 · Grant · Acquired 1,319 · Balance 1,319 F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029.
F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HUMANA INC
Report date July 01, 2024 · Filed July 01, 2024
Section 16 reporting ended · disclosed 2024-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | Direct | 85,130 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 85,130 F8: Includes 21,786 restricted stock units granted on 2/21/24, representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. |
| Humana CommonSEC Table I · non-derivative | IndirectSee Footnote | 25,000 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 25,000 F9: Shares transferred to GRAT effective January 30, 2024 in which reporting person is sole trustee. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $350.79 · Expires 2027-02-24 | Direct | 13,430 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 13,430 F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $376.61 · Expires 2028-02-22 | Direct | 30,425 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 30,425 F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments on 2/22/22, 2/22/23, & 2/22/24. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $425.06 · Expires 2029-02-21 | Direct | 23,734 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 23,734 F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments on 2/21/23, 2/21/24, & 2/21/25. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $510.24 · Expires 2030-02-24 | Direct | 26,484 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 26,484 F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,184 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 2,184 F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,573 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 4,573 F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments.
F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments on 2/22/22, 2/22/23, & 2/22/24.
F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments on 2/21/23, 2/21/24, & 2/21/25.
F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F6: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F7: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
F8: Includes 21,786 restricted stock units granted on 2/21/24, representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
F9: Shares transferred to GRAT effective January 30, 2024 in which reporting person is sole trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2018 Filed May 7, 2018 19:13 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 39,147 | $0.00 Strike: $167.81 | $0.00 |
DisclosureSEC source: 0000049071-18-000067 · edgar.xml · derivative · entry 11 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,147 Underlying: Humana Common · 39,147 shares Expires 2023-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:13 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 39,542 | $0.00 Strike: $164.65 | $0.00 |
DisclosureSEC source: 0000049071-18-000067 · edgar.xml · derivative · entry 10 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 39,542 shares Expires 2022-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. F1 · derivative.exercise_date: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:13 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 17,604 | $286.17 | $5,037,694.43 |
DisclosureSEC source: 0000049071-18-000067 · edgar.xml · nonDerivative · entry 9 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,085 F11 · price: Shares sold at prices ranging from $285.95 to $286.475. Price reported is weighted average sales price. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:13 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 7,469 | $284.78 | $2,126,984.48 |
DisclosureSEC source: 0000049071-18-000067 · edgar.xml · nonDerivative · entry 8 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,689 F10 · price: Shares swapped for payment of taxes on stock option exercise using fair market value on May 3, 2018 pursuant to Humana Inc's 2011 Stock Incentive Plan. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:13 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 22,878 | $287.14 | $6,569,188.92 |
DisclosureSEC source: 0000049071-18-000067 · edgar.xml · nonDerivative · entry 7 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,158 F9 · price: Shares swapped for payment of purchase price on stock option exercise using fair market value on May 2, 2018 pursuant to Humana Inc's 2011 Stock Incentive Plan. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:13 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 39,147 | $167.81 | $6,569,062.34 |
DisclosureSEC source: 0000049071-18-000067 · edgar.xml · nonDerivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:13 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 7,630 | $284.78 | $2,172,833.25 |
DisclosureSEC source: 0000049071-18-000067 · edgar.xml · nonDerivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,889 F10 · price: Shares swapped for payment of taxes on stock option exercise using fair market value on May 3, 2018 pursuant to Humana Inc's 2011 Stock Incentive Plan. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:13 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 22,326 | $287.14 | $6,410,687.64 |
DisclosureSEC source: 0000049071-18-000067 · edgar.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,519 F9 · price: Shares swapped for payment of purchase price on stock option exercise using fair market value on May 2, 2018 pursuant to Humana Inc's 2011 Stock Incentive Plan. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:13 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 38,935 | $164.65 | $6,410,453.08 |
DisclosureSEC source: 0000049071-18-000067 · edgar.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:13 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 349 | $287.14 | $100,211.86 |
DisclosureSEC source: 0000049071-18-000067 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,910 F9 · price: Shares swapped for payment of purchase price on stock option exercise using fair market value on May 2, 2018 pursuant to Humana Inc's 2011 Stock Incentive Plan. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:13 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 607 | $164.65 | $99,939.52 |
DisclosureSEC source: 0000049071-18-000067 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 23:42 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 14,075 | $274.32 | $3,861,032.89 |
DisclosureSEC source: 0000049071-18-000046 · edgar.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,652 F10 · price: Shares sold at prices ranging from $273.4801 to $275.26. Price reported is weighted average sales price. Read SEC document |
| February 24, 2018 Filed Feb 27, 2018 23:42 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 11,169 | $269.31 | $3,007,923.39 |
DisclosureSEC source: 0000049071-18-000046 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,727 Read SEC document |
| February 24, 2018 Filed Feb 27, 2018 23:42 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 25,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-18-000046 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · shares: Includes Performance Stock Units that vested on 2/24/2018. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 20:04 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 10,243 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-18-000028 · edgar.xml · derivative · entry 8 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,243 Underlying: Humana Common · 10,243 shares Expires not disclosed F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/19/2018, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/19/2018, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 20:04 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 44,152 | $0.00 Strike: $268.47 | $0.00 |
DisclosureSEC source: 0000049071-18-000028 · edgar.xml · derivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,152 Underlying: Humana Common · 44,152 shares Expires 2025-02-19 F4 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three annual increments. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three annual increments. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 17:18 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 8,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000188 · edgar.xml · derivative · entry 7 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,252 Underlying: Humana Common · 8,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017, 33% of the award is vesting on 12/15/17, 12/15/18, and 12/15/19. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017, 33% of the award is vesting on 12/15/17, 12/15/18, and 12/15/19. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 17:18 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 8,690 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000188 · edgar.xml · derivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,693 Underlying: Humana Common · 8,690 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 17:18 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 8,249 | $253.62 | $2,092,111.38 |
DisclosureSEC source: 0000049071-17-000188 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,652 Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 17:18 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 16,815 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000188 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2017 Filed Aug 14, 2017 20:21 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 12,000 | $251.88 | $3,022,604.40 |
DisclosureSEC source: 0000049071-17-000152 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,086 F7 · price: Shares sold at prices ranging from $251.36 to $252.24. Price reported is the average sale price. Read SEC document |
| July 26, 2017 Filed Jul 26, 2017 20:09 UTC | KEYCORP /NEW/ KEY · Entity 3220 | PurchaseCommon Shares | 2,500 | $18.17 | $45,425.00 |
DisclosureSEC source: 0001294671-17-000076 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Read SEC document |
| May 18, 2017 Filed May 22, 2017 20:28 UTC | KEYCORP /NEW/ KEY · Entity 3220 | GrantDeferred Shares · Derivative | 6,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001294671-17-000052 · edgar.xml · derivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,191 Underlying: Common Shares · 6,787 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F3 · price: The Deferred Shares were awarded under the Deferred Share Plan. F2 · derivative.exercise_date: Under the terms of KeyCorp's Directors' Deferred Share Sub-Plan of the KeyCorp 2013 Equity Compensation Plan (the "Deferred Share Plan"), the Particpant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 18, 2020. F2 · derivative.expiration_date: Under the terms of KeyCorp's Directors' Deferred Share Sub-Plan of the KeyCorp 2013 Equity Compensation Plan (the "Deferred Share Plan"), the Particpant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 18, 2020. F4 · balance_after: Includes approximately 356 dividend-equivalent Deferred Shares accrued between June 2016 and March 2017. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:04 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 39,147 | $0.00 Strike: $167.81 | $0.00 |
DisclosureSEC source: 0000049071-17-000106 · edgar.xml · derivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,294 Underlying: Humana Common · 39,147 shares Expires 2023-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:04 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 79,084 | $0.00 Strike: $164.65 | $0.00 |
DisclosureSEC source: 0000049071-17-000106 · edgar.xml · derivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,542 Underlying: Humana Common · 79,084 shares Expires 2022-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. F1 · derivative.exercise_date: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:04 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 118,231 | $225.82 | $26,699,149.06 |
DisclosureSEC source: 0000049071-17-000106 · edgar.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,086 F7 · price: Shares sold at prices ranging from $224.65 to $228.71. Price reported is the average sale price. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:04 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 39,147 | $167.81 | $6,569,062.34 |
DisclosureSEC source: 0000049071-17-000106 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 4, 2017 20:04 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 79,084 | $164.65 | $13,020,785.18 |
DisclosureSEC source: 0000049071-17-000106 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:37 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 21,272 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000078 · edgar.xml · derivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,272 Underlying: Humana Common · 21,272 shares Expires not disclosed F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017,vesting in three annual increments. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017,vesting in three annual increments. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 22:37 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 92,489 | $0.00 Strike: $217.42 | $0.00 |
DisclosureSEC source: 0000049071-17-000078 · edgar.xml · derivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,489 Underlying: Humana Common · 92,489 shares Expires 2024-03-08 F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. Read SEC document |
| March 08, 2017 Filed Apr 10, 2017 16:32 UTC Amendment | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 24,377 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-009771 · doc4a.xml · derivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,377 Underlying: Humana Common · 24,377 shares Expires not disclosed F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · security: Due to a scrivener's error, original Form 4 misstated the number of shares. F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 03/08/2017,vesting in three annual increments. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 03/08/2017,vesting in three annual increments. Read SEC document |
| March 08, 2017 Filed Apr 10, 2017 16:32 UTC Amendment | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 105,988 | $217.42 Strike: $217.42 | $23,043,381.02 |
DisclosureSEC source: 0000899243-17-009771 · doc4a.xml · derivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,988 Underlying: Humana Common · 105,988 shares Expires 2024-03-08 F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. F7 · security: Due to a scrivener's error, original Form 4 misstated the number of shares. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 50,286 | $0.00 Strike: $102.16 | $0.00 |
DisclosureSEC source: 0000049071-17-000029 · edgar.xml · derivative · entry 8 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 50,286 shares Expires 2021-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/18/14, vesting in three increments from 02/18/15 to 02/18/17. F2 · derivative.exercise_date: Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/18/14, vesting in three increments from 02/18/15 to 02/18/17. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 17,335 | $0.00 Strike: $72.84 | $0.00 |
DisclosureSEC source: 0000049071-17-000029 · edgar.xml · derivative · entry 7 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 17,335 shares Expires 2020-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to the Company's 2003 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/20/13, vesting in three increments from 02/20/14 to 02/20/16. F1 · derivative.exercise_date: Right to buy pursuant to the Company's 2003 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/20/13, vesting in three increments from 02/20/14 to 02/20/16. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:43 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 104,256 | $205.23 | $21,396,771.65 |
DisclosureSEC source: 0000049071-17-000029 · edgar.xml · nonDerivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,086 F9 · price: Shares sold at prices ranging from $203.62 to $206.39. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:43 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 974 | $205,325.00 | $199,986,550.00 |
DisclosureSEC source: 0000049071-17-000029 · edgar.xml · nonDerivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196.342 Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 50,286 | $102.16 | $5,136,966.33 |
DisclosureSEC source: 0000049071-17-000029 · edgar.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 17,335 | $72.84 | $1,262,681.40 |
DisclosureSEC source: 0000049071-17-000029 · edgar.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2017 Filed Feb 22, 2017 23:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 16,519 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000029 · edgar.xml · derivative · entry 11 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 16,519 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to Reporting Person on 02/18/2014, 100% of the award is vesting on 02/18/17. F6 · derivative.expiration_date: Restricted stock units granted to Reporting Person on 02/18/2014, 100% of the award is vesting on 02/18/17. Read SEC document |
| February 18, 2017 Filed Feb 22, 2017 23:43 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 25,413 | $205.33 | $5,217,924.23 |
DisclosureSEC source: 0000049071-17-000029 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,695 Read SEC document |
| February 18, 2017 Filed Feb 22, 2017 23:43 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 53,257 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000029 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · shares: Includes both time based (16,519) and performance based (36,738) based restricted stock units that vested on 2/18/17. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 18:40 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 8,689 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000194 · edgar.xml · derivative · entry 8 BROUSSARD BRUCE D · CIK 0001185643 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,383 Underlying: Humana Common · 8,689 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 18:40 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 4,262 | $206.60 | $880,507.89 |
DisclosureSEC source: 0000049071-16-000194 · edgar.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,851 Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 18:40 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 8,689 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000194 · edgar.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,113 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.